CBD oil pictured with an article about migraine research

CBD and Migraines UK: What Does the Research Show?

Can CBD Help Migraines?

CBD has attracted considerable interest from people living with migraine, and cannabinoids have been studied for their possible effects on pain signalling, inflammation and the nervous system.

Until recently, however, much of the evidence surrounding cannabis, CBD and migraine came from laboratory research, observational studies and reports from people already using cannabis.

In 2026, researchers published an important randomized, double-blind, placebo-controlled trial examining cannabinoids during acute migraine attacks.

The result is particularly relevant when discussing CBD.

The CBD-dominant treatment was not significantly better than placebo for the trial's main migraine outcomes.

A combination containing both THC and CBD performed better than placebo, but that was a very different cannabinoid preparation from a retail CBD-isolate oil.

So what does this mean for somebody searching for CBD oil for migraines?

The most accurate answer is:

CBD remains an interesting area of migraine research, but current evidence does not establish ordinary retail CBD oil as an effective migraine treatment.

It is therefore important to separate genuine cannabinoid research from claims that CBD oil has been proven to relieve, prevent or treat migraine.

What Is a Migraine?

Migraine is a neurological condition rather than simply another name for a bad headache.

Migraine attacks can include moderate or severe head pain, often described as throbbing or pulsating, as well as symptoms such as:

  • nausea
  • vomiting
  • sensitivity to light
  • sensitivity to sound
  • difficulty carrying out normal activities.

Some people experience migraine with aura, which can involve temporary visual symptoms, sensory symptoms or speech disturbance.

Migraine varies considerably between individuals. Some people have attacks only occasionally, while others experience them much more frequently.

The NHS says migraine cannot currently be cured, although treatments can help manage attacks and reduce their frequency. Its current migraine page was last reviewed on 10 March 2026. Read NHS migraine guidance.

Why Have Scientists Been Interested in CBD and Migraine?

There are legitimate biological reasons for studying cannabinoids in migraine.

The body's endocannabinoid system is involved in several processes relevant to neurological research, while CBD interacts with numerous receptors and signalling pathways beyond the classical cannabinoid receptors.

Scientists have investigated possible connections involving:

  • pain signalling
  • inflammatory pathways
  • serotonin-related signalling
  • nausea
  • nervous-system activity
  • endocannabinoid signalling.

These mechanisms help explain why cannabinoids have attracted research interest.

But a plausible biological mechanism is not the same thing as evidence that a consumer CBD oil treats migraine.

Laboratory findings and theories have to be tested in properly controlled human studies.

Our separate CBD and Inflammation UK article examines this same distinction in greater detail: interesting biological effects should not automatically be converted into consumer treatment claims.

What Did the 2026 Migraine Trial Test?

The 2026 study was important because it was a randomized, double-blind, placebo-controlled crossover trial.

Researchers enrolled 92 adults with migraine.

Participants treated as many as four separate migraine attacks, with each attack receiving one of four vaporised cannabis preparations:

  • 6% THC-dominant cannabis
  • 11% CBD-dominant cannabis
  • 6% THC + 11% CBD cannabis
  • placebo cannabis containing neither active treatment.

There was at least a one-week washout period between treated attacks.

Altogether, 247 migraine attacks were treated.

Researchers assessed three particularly important outcomes two hours after treatment:

  1. pain relief
  2. complete pain freedom
  3. freedom from the participant's most bothersome migraine symptom.

This design is considerably stronger for determining cause and effect than simply asking existing cannabis users whether they believe cannabis helps their migraines. Read the 2026 randomized trial on PubMed.

What Happened With the CBD-Dominant Treatment?

This is the finding most relevant to people searching for CBD oil.

The 11% CBD-dominant treatment was not superior to placebo for:

  • pain relief
  • pain freedom
  • freedom from the most bothersome symptom

at the two-hour assessment.

That does not prove that every possible CBD formulation, dose or route of administration will always produce the same result.

The researchers tested a particular vaporised CBD-dominant cannabis flower, not Valley CBD oil and not an oral CBD-isolate preparation.

But it does mean we cannot point to this major clinical trial as evidence that CBD successfully treats an acute migraine attack.

In fact, its CBD-specific result points in the opposite direction: the CBD-dominant preparation did not demonstrate superiority over placebo on the primary acute outcomes studied.

What Happened With THC and CBD Together?

The result was different when THC and CBD were combined.

The 6% THC + 11% CBD treatment was superior to placebo at two hours for:

  • pain relief
  • pain freedom
  • freedom from the most bothersome symptom.

For example, pain relief occurred in 67.2% of attacks treated with THC+CBD compared with 46.6% with placebo.

Pain freedom occurred in 34.5% compared with 15.5% for placebo.

The THC+CBD treatment also showed some sustained effects at later assessments.

This is scientifically interesting.

But it is extremely important not to turn that finding into:

“CBD oil has been clinically proven to help migraine.”

That is not what the trial showed.

The successful experimental treatment contained THC as well as CBD, was administered by vaporisation and was used under clinical-trial conditions.

Valley CBD oils use CBD isolate, so this result cannot be transferred to our products.

What About THC on Its Own?

The THC-dominant treatment also showed a more limited result.

It was superior to placebo for pain relief at two hours but was not superior for complete pain freedom or freedom from the most bothersome symptom.

Again, this tells us that the cannabinoid story is much more complicated than simply saying:

“Cannabis works for migraines.”

Different cannabinoids, combinations, doses, formulations and methods of administration can produce different results.

That is precisely why evidence from THC-containing cannabis should not be used to market a CBD-isolate oil.

Does the 2026 Study Prove CBD Oil Does Not Work for Migraines?

No.

It is important to be just as careful in this direction.

The trial did not test oral CBD-isolate oil, so it cannot prove that every form of oral CBD is ineffective for every aspect of migraine.

What it does tell us is narrower and more defensible:

In this high-quality acute migraine trial, the CBD-dominant treatment did not outperform placebo on the principal two-hour migraine outcomes.

Further research could examine:

  • oral CBD
  • different CBD doses
  • CBD isolate specifically
  • longer-term preventive use
  • different formulations
  • different patient populations.

Until those questions are adequately answered, we should neither claim that CBD works nor claim that every possible CBD approach has conclusively failed.

What Did Earlier CBD and Migraine Research Show?

Before the 2026 randomized trial, much of the enthusiasm around cannabinoids and migraine came from less definitive evidence.

Reviews have discussed:

  • laboratory research
  • biological mechanisms
  • observational studies
  • retrospective medical-cannabis data
  • patient-reported outcomes
  • studies involving products containing both THC and CBD.

A 2023 review described the evidence as preliminary and called for randomized controlled trials capable of identifying appropriate cannabinoid formulations, dosages and indications.

A dedicated 2025 clinical review also examined whether CBD should be used in migraine, demonstrating that the question remained active immediately before the major randomized trial was published. Read the 2025 review on PubMed.

This explains why older websites can sound considerably more optimistic about CBD and migraine than the evidence now justifies.

Does CBD Reduce Migraine Pain?

CBD is widely discussed in relation to pain research.

However, evidence for CBD and pain generally should not automatically be applied to migraine.

Migraine is a specific neurological disorder.

The strongest direct randomized migraine evidence currently available did not show superior acute pain outcomes for the CBD-dominant treatment compared with placebo.

Our separate CBD Oil and Pain UK guide examines CBD's broader pain evidence without assuming that a result in one pain condition applies to another.

Does CBD Reduce Migraine Inflammation?

Inflammatory and neuroinflammatory processes are studied as part of migraine biology.

CBD also influences inflammatory pathways in laboratory and preclinical experiments.

But it would be misleading to combine those facts into:

“CBD reduces the inflammation that causes migraines.”

Human evidence does not currently establish Valley CBD oil as an anti-inflammatory migraine treatment.

Mechanism research can help scientists decide what to investigate.

It does not by itself establish a clinical outcome.

Does CBD Help Migraine Nausea?

Nausea and vomiting can be major components of migraine attacks.

Cannabinoids are also studied in nausea in other medical settings.

But research from one form of nausea cannot simply be transferred to migraine-associated nausea.

The 2026 migraine trial examined freedom from the participant's most bothersome symptom, which could vary between participants, rather than establishing retail CBD oil as a specific anti-nausea treatment.

The CBD-dominant treatment was not superior to placebo for freedom from the most bothersome symptom at two hours.

So we should not describe CBD oil as a proven treatment for migraine nausea.

Can Taking CBD Every Day Prevent Migraines?

This question is different from treating an attack that has already begun.

The 2026 trial investigated acute treatment.

It did not establish whether taking CBD every day prevents future migraine attacks.

The researchers themselves noted that the study did not examine regular long-term administration or possible preventive effects.

So the trial cannot answer whether daily CBD reduces migraine frequency.

More importantly for a retail CBD company, there is currently no basis for recommending daily Valley CBD oil as a migraine-prevention programme.

We should not tell customers that consistent CBD use will make attacks less frequent or less severe.

Is Higher-Strength CBD Better for Migraines?

There is no reliable clinical evidence showing that a stronger retail CBD oil is better for migraine.

CBD strength tells you the concentration of CBD in a product.

It does not establish medical effectiveness.

For example:

40% CBD contains more CBD per volume than 10% CBD.

That is a measurable composition fact.

But:

40% CBD treats migraine better than 10% CBD

would be a treatment claim unsupported by adequate evidence.

The old migraine pages made the mistake of moving from CBD concentration into effectiveness.

The new article deliberately keeps those concepts separate.

Is CBD Isolate Better Than Full-Spectrum or Broad-Spectrum CBD for Migraines?

There is currently no convincing clinical evidence establishing CBD isolate, broad-spectrum CBD or full-spectrum CBD as the superior retail extract type for migraine.

The old article suggested that many people prefer full-spectrum or broad-spectrum products because an “entourage effect” might provide more comprehensive migraine benefits.

That is too speculative for a migraine guide.

It also conflicts with Valley CBD's actual formulation.

Valley CBD uses CBD isolate.

We can state that composition fact clearly.

But we should not claim isolate is better for migraine, and we should not promote other extract types as more effective either.

Does the THC+CBD Trial Support the “Entourage Effect”?

Not in the way the phrase is often used in marketing.

The 2026 trial found different outcomes between CBD-dominant, THC-dominant and combined THC+CBD cannabis.

That is important research.

However, one trial involving one THC:CBD ratio and one delivery method does not establish that every full-spectrum product is more effective because of a general “entourage effect”.

It certainly does not establish that an over-the-counter hemp product will reproduce the trial result.

The safest interpretation is simply that different cannabinoid compositions produced different outcomes in this particular migraine trial.

What About Applying CBD Balm to the Temples?

There is not good clinical evidence establishing CBD balm applied to the temples or forehead as a migraine treatment.

The previous article suggested topical application as a method for headache relief.

That recommendation should disappear.

Research on a swallowed CBD oil, vaporised cannabis or a specially formulated clinical topical product cannot automatically be transferred to an unrelated balm.

Migraine originates from complex neurological processes. Applying a topical product near the location of perceived pain does not establish that the underlying migraine is being treated.

What About Vaping CBD for Migraine?

The fact that researchers used vaporisation in the 2026 clinical trial should not be interpreted as advice for consumers to vape CBD for migraine.

Clinical trials choose specific administration methods in controlled environments to answer research questions.

The study does not provide evidence that consumers should start vaping CBD products to self-treat migraine.

Valley CBD does not need to recommend vaping at all in this article.

How Much CBD Should I Take for a Migraine?

There is no established retail CBD dose for treating migraine.

That distinction is particularly important in the UK.

The Food Standards Agency advises healthy adults consuming CBD foods not to exceed 10mg of CBD per day.

This is a consumer-safety recommendation.

It is not a migraine treatment dose.

The FSA also advises people taking medication to avoid consuming CBD unless under medical direction. It gives similar advice to people with underlying health conditions, and advises children under 18, people who are pregnant or breastfeeding, and those trying to conceive to avoid CBD.

The old article recommended beginning with 10–20mg and gradually increasing the amount.

That recommendation conflicts with current FSA guidance and is being removed completely. Read current FSA guidance.

Can CBD Interact With Migraine Medication?

CBD can interact with medications.

The exact importance of an interaction depends on the medicine, dose and individual circumstances.

Many people with migraine use medicines during attacks, preventive medicines, or both.

That makes it particularly inappropriate for a CBD retailer to advise somebody to add CBD to their migraine-treatment regimen without considering their medication.

The FSA currently advises people taking medication not to consume CBD unless under medical direction.

What Does the NHS Recommend for Migraine?

The NHS currently lists established treatments for acute migraine attacks including:

  • painkillers such as ibuprofen and paracetamol
  • triptans
  • gepants
  • medicines for nausea and vomiting.

For preventing migraine, treatment can include certain:

  • beta blockers
  • antidepressants
  • epilepsy medicines
  • other preventive treatments depending on circumstances.

The NHS also discusses options including acupuncture, relaxation techniques, cognitive behavioural therapy and vitamin B2, together with lifestyle measures.

CBD is not listed as a standard migraine treatment on the NHS migraine page.

NICE migraine guidance similarly covers established acute and preventive approaches, including triptans, NSAIDs, paracetamol, anti-emetics and newer treatments such as rimegepant in appropriate patients. Read NICE headache and migraine guidance.

What Do UK Rules Say About CBD and Migraine Claims?

For CBD products sold as foods, including orally consumed CBD oils, the FSA's position is very clear.

The FSA states that there are no authorised health claims for CBD food products and that claims that CBD foods relieve pain or treat illness are not permitted.

The FSA specifically answers the question of whether CBD foods have proven health or medical benefits for pain, anxiety or sleep with:

No.

That makes statements such as:

  • “CBD oil relieves migraines”
  • “CBD prevents migraine attacks”
  • “our CBD reduces migraine pain”
  • “high-strength CBD controls migraine symptoms”

inappropriate for a retail CBD food product.

The purpose of this article is therefore educational:

to explain what migraine research involving cannabinoids actually shows without converting the science into a product claim.

Are Medical Cannabis and Retail CBD Oil the Same Thing?

No.

This is another important source of confusion.

Research involving prescribed cannabis-based medicinal products, THC-containing preparations or specially manufactured clinical formulations does not automatically apply to an ordinary retail CBD food.

Likewise, evidence supporting licensed cannabinoid medicines for specific conditions does not establish that CBD supplements treat unrelated conditions.

NICE treats cannabis-based medicinal products within a distinct clinical framework and has specific recommendations for particular indications. Migraine is not one of the established CBD indications listed there. Read NICE cannabis-based medicinal products guidance.

Should Someone Stop Their Migraine Medication and Try CBD Instead?

No.

CBD should not be presented as a replacement for prescribed or recommended migraine treatment.

A person whose current migraine treatment is not working should discuss this with an appropriate healthcare professional rather than replacing their medicine with a CBD product.

The NHS notes that several treatment approaches are available and that people whose symptoms do not respond or become worse may be referred for further assessment and specialist treatment.

Can Migraine Triggers Still Be Useful to Track?

Yes.

This is one area where practical information can be useful without making a CBD claim.

The NHS notes that some people identify triggers associated with their migraine attacks, including:

  • stress
  • tiredness
  • irregular meals
  • caffeine
  • menstrual periods
  • insufficient regular exercise.

Keeping a migraine diary can help identify patterns.

The NHS also recommends measures such as staying hydrated, eating regularly, getting enough sleep and trying to manage stress.

These are general migraine-management considerations.

They do not mean CBD is required as part of that routine.

Frequently Asked Questions

Can CBD oil help migraines?

CBD is being researched in relation to migraine, but current evidence does not establish ordinary retail CBD oil as an effective migraine treatment.

The strongest randomized migraine trial so far found that a CBD-dominant vaporised treatment was not superior to placebo for its principal two-hour migraine outcomes.

Has CBD been clinically tested for migraines?

Yes, cannabinoids have now been tested in a randomized, double-blind, placebo-controlled acute migraine trial.

However, the study tested vaporised cannabis preparations rather than oral CBD-isolate oil.

Did CBD work in the 2026 migraine study?

The CBD-dominant arm was not superior to placebo for pain relief, pain freedom or freedom from the most bothersome symptom at two hours.

Did THC and CBD together work?

The THC+CBD treatment performed better than placebo on several outcomes in that trial.

However, it contained THC and was vaporised cannabis, so the result cannot be used to claim that retail CBD-isolate oil treats migraine.

Does this prove CBD oil cannot help migraine?

No.

The study did not test every CBD formulation or oral CBD-isolate oil.

It shows that the specific CBD-dominant treatment tested did not outperform placebo on the main acute migraine outcomes.

More research is needed before stronger conclusions can be drawn about other formulations or preventive use.

Can CBD prevent migraines?

There is not good clinical evidence establishing retail CBD oil as a migraine-prevention treatment.

The 2026 randomized trial studied treatment of individual acute attacks rather than long-term prevention.

Does CBD help migraine nausea?

CBD oil has not been established as a treatment for migraine-associated nausea.

The CBD-dominant arm of the 2026 study was not superior to placebo for freedom from the participant's most bothersome symptom.

Is high-strength CBD better for migraine?

There is no good clinical evidence showing that a higher CBD concentration is more effective against migraine simply because it contains more CBD.

Is CBD isolate better for migraines?

There is no good clinical evidence establishing CBD isolate as superior to full-spectrum or broad-spectrum CBD for treating migraine.

Valley CBD uses CBD isolate, but that composition fact should not be turned into a migraine-effectiveness claim.

How much CBD should I take for migraine?

There is no established retail CBD treatment dose for migraine.

For CBD foods, the FSA currently advises healthy adults not to exceed 10mg CBD per day. This is safety guidance, not a migraine-treatment dosage.

People taking medication or with underlying health conditions are advised to avoid consuming CBD unless under medical direction.

Can CBD replace migraine medication?

No.

CBD products should not replace prescribed or recommended migraine treatments.

The Bottom Line

CBD and other cannabinoids remain legitimate areas of migraine research.

For years, much of the discussion was based on biological mechanisms, observational evidence and studies involving mixed cannabis preparations.

The 2026 randomized, double-blind, placebo-controlled trial substantially improves the evidence base.

Its results are particularly important for CBD:

the CBD-dominant treatment did not outperform placebo for pain relief, complete pain freedom or freedom from the most bothersome migraine symptom at two hours.

The THC+CBD preparation did perform better than placebo on several outcomes, but this was THC-containing vaporised cannabis and should not be presented as evidence for CBD-isolate oil.

So the current evidence supports saying:

Cannabinoids continue to be investigated in migraine research, and different cannabinoid preparations may produce different outcomes.

It does not support saying:

Valley CBD oil treats migraines, relieves migraine pain, prevents attacks or works better when a higher strength is used.

For someone living with migraine, established NHS treatment and appropriate medical advice remain important.

This article is for general educational information only and is not medical advice. Valley CBD products are not intended to diagnose, treat, cure or prevent disease.

Sources

Back to blog